Research news

Vision tests predict cognitive decline linked to Parkinson's

Date

19 January 2021

New guidance for lab-based researchers on patient and public involvement

Date

8 January 2021

Levodopa-making tomatoes could provide an affordable medication for Parkinson's symptoms

Date

11 December 2020

Can cannabis stop Parkinson's hallucinations?

Date

14 October 2019

A pioneering clinical trial will investigate if cannabidiol (CBD) – a compound found in the cannabis plant – can treat hallucinations and delusions in people living with Parkinson’s.

Promising results from a phase II study for people with early-stage Parkinson’s

Date

8 October 2019

A phase II clinical trial of tavapadon, a drug developed by Cerevel Therapeutics, has shown improvements in movement symptoms. The results have been announced on the company website.

New guide to help charities and patients work with drug companies

Date

1 October 2019

A new guide has been launched to help charities support patients to have their say on research carried out by the pharmaceutical industry.

Research conference

Tickets for our national research conference are on sale

Date

25 September 2019

This event, for anyone with an interest in Parkinson’s research, will take place on Saturday 23 November at the Cranmore Park Conference & Events Centre, outside Birmingham.

Research shows at home exercise improves movement symptoms

Date

19 September 2019

Researchers have shown that those taking part in a home-based exercise programme experienced improvements in their motor symptoms.

Prostate drug shows promise in Parkinson’s

Date

17 September 2019

A drug used to treat enlarged prostates may have exciting potential for slowing down Parkinson's, according to research published in the Journal of Clinical Investigation.

Scientists uncover further evidence that Parkinson's could start in the gut

Date

6 September 2019

New research in rats has shown that alpha-synuclein, an abnormal protein normally found in brain cells affected in Parkinson's, can move rapidly from the gut to the brain. These findings support growing evidence that Parkinson’s may start in the gut rather than the brain.

Hormone treatment slows Parkinson's symptoms in mice

Date

20 August 2019

Researchers have shown that boosting levels of oestrogen in the brains of mice improved symptoms by slowing the build-up of the toxic protein alpha-synuclein.

United in the search for better treatments

Date

19 August 2019

The Critical Path for Parkinson's meeting brought together pharmaceutical companies, universities, charities and regulatory bodies to address barriers to new treatments.

New Sheffield based Virtual Biotech programme aims to save brain cells

Date

6 August 2019

We’re investing £100,000 to improve compounds that have the potential to boost the function of brain cell batteries and slow the progression of Parkinson’s.